Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TTY Biopharm Company Limited (4105) Financial Statements

TTY Biopharm Company Limited Financial Overview

TTY Biopharm Company Limited's market cap is currently NT$20.44B. The company's EPS TTM is NT$6.96; its P/E ratio is 12.48; and it has a dividend yield of 5.48%. TTY Biopharm Company Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 6.45BNT$ 5.89BNT$ 5.51BNT$ 5.06BNT$ 4.54B
Gross ProfitNT$ 3.72BNT$ 3.41BNT$ 3.22BNT$ 3.02BNT$ 2.77B
Operating IncomeNT$ 1.70BNT$ 1.39BNT$ 1.38BNT$ 1.23BNT$ 1.11B
EBITDANT$ 1.90BNT$ 1.73BNT$ 1.66BNT$ 1.50BNT$ 1.14B
Net IncomeNT$ 1.56BNT$ 1.45BNT$ 1.13BNT$ 1.09BNT$ 831.89M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.99BNT$ 3.08BNT$ 2.82BNT$ 2.68BNT$ 2.59B
Total AssetsNT$ 11.35BNT$ 10.86BNT$ 9.87BNT$ 9.60BNT$ 9.30B
Total DebtNT$ 1.23BNT$ 1.76BNT$ 1.92BNT$ 1.87BNT$ 2.20B
Net DebtNT$ -1.30BNT$ -1.01BNT$ -705.98MNT$ -488.94MNT$ -20.11M
Total LiabilitiesNT$ 3.30BNT$ 3.35BNT$ 3.37BNT$ 3.37BNT$ 3.53B
Stockholders' EquityNT$ 7.24BNT$ 6.75BNT$ 5.94BNT$ 5.66BNT$ 5.17B
Cash Flow
Free Cash FlowNT$ 1.61BNT$ 1.22BNT$ 985.73MNT$ 1.10BNT$ 1.18B
Operating Cash FlowNT$ 1.76BNT$ 1.35BNT$ 1.09BNT$ 1.24BNT$ 1.26B
Investing Cash FlowNT$ -367.36MNT$ -243.56MNT$ -2.63MNT$ -133.14MNT$ -168.78M
Financing Cash FlowNT$ -1.59BNT$ -1.05BNT$ -816.33MNT$ -1.10BNT$ -850.05M

Currency in TWD

TTY Biopharm Company Limited Earnings and Revenue History

02.5B5B7.5B17.5 %20 %22.5 %25 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

TTY Biopharm Company Limited Liabilities to Assets

04B8B12B28 %32 %36 %40 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

TTY Biopharm Company Limited Cash Flow

-2B-1B01B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

TTY Biopharm Company Limited Forecast EPS vs Actual EPS

11.31.51.822.32.5Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >